Geopolitics Alpha

Zeria Pharmaceutical Co Ltd - Notice Concerning Acquisition Of Equity Interests Of Haupt Pharma Wulfling GmbH (Making It A Sub-Subsidiary) By A Consolidated Subsidiary

Published . Updated .

Zeria Pharmaceutical Co Ltd - Notice Concerning Acquisition Of Equity Interests Of Haupt Pharma Wulfling GmbH (Making It A Sub-Subsidiary) By A Consolidated Subsidiary

Select market data provided by ICE Data Services . Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC filings

Directly affected

  • FDS Factset Research Systems

    Named in this report.

Indirectly affected

  • No related companies are mapped for this report yet.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
FDSNo price data for this ticker———————

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Zeria Pharmaceutical Co Ltd - Notice Concerning Acquisition Of Equity Interests Of Haupt Pharma Wulfling GmbH (Making It A Sub-Subsidiary) By A Consolidated Subsidiary TradingView

Source: TradingView

This story

CompanyWhenMoveStatus
GLDthree days earlier+3.37%final price
GLDfive days earlier+3.56%final price
QQQthree days earlier+2.99%final price
QQQfive days earlier+2.00%final price
SPYthree days earlier+1.75%final price
SPYfive days earlier+0.89%final price
TLTthree days earlier-1.35%final price
TLTfive days earlier-2.31%final price

This story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Zeria Pharmaceutical Co Ltd - Notice Concerning Acquisition Of Equity Interests Of Haupt Pharma Wulfling GmbH (Making It A Sub-Subsidiary) By A Consolidated Subsidiary” scores 12 out of 100. The score uses 1 sources.